OKUR (OnKure Therapeutics) FCF Yield % : -121.67 (As of Apr. 05, 2025)

View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, OnKure Therapeutics's Trailing 12-Month Free Cash Flow is $-51.17 Mil, and Market Cap is $41.92 Mil. Therefore, OnKure Therapeutics's FCF Yield % for today is -121.67%.

The historical rank and industry rank for OnKure Therapeutics's FCF Yield % or its related term are showing as below:

OKUR' s FCF Yield % Range Over the Past 10 Years
Min: -122.06 Med: 0 Max: 0
Current: -121.67

OKUR's FCF Yield % is ranked worse than
82.03% of 1497 companies
in the Biotechnology industry
Industry Median: -15.53 vs OKUR: -121.67

OnKure Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

OnKure Therapeutics FCF Yield % Historical Data

The historical data trend for OnKure Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics FCF Yield % Chart

OnKure Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

FCF Yield %

-44.58

OnKure Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial				-	-	-	-	-73.41

Competitive Comparison of OnKure Therapeutics's FCF Yield %

For the Biotechnology subindustry, OnKure Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OnKure Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OnKure Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where OnKure Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

OnKure Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

OnKure Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-51.169	/	114.7842
	=	-44.58%

OnKure Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-21.065	*	4	/	114.7842
	=	-73.41%

OnKure Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

OnKure Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301

Website

https://www.onkuretherapeutics.com

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.